908 Devices, Inc. (NASDAQ:MASS) Q2 2023 Earnings Conference Call August 8, 2023 8:30 AM ET

Company Participants

Kelly Gura - IR

Kevin Knopp - Co-Founder, CEO, President & Director

Joseph Griffith - CFO & Treasurer

Conference Call Participants

Daniel Arias - Stifel

Steven Mah - TD Cowen

Matthew Larew - William Blair

Operator

Hello, and welcome to today's 908 Devices Second Quarter 2023 Financial Results Conference Call. My name is Jordan, and I'll be coordinating your call today. [Operator Instructions]

I'm now going to hand over to Kelly Gura, Investor Relations to begin. Kelly, please go ahead.

Kelly Gura

Thank you. This morning, 908 Devices released financial results for the second quarter ended June 30, 2023. If you've not received this news release or if you'd like to be added to the company's distribution list, please send an e-mail to ir@908devices.com. Joining me today from 908 is Kevin Knopp, Chief Executive Officer and Co-Founder, and Joe Griffith, Chief Financial Officer.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. Additional information regarding these risks and uncertainties appears in the section entitled Forward-Looking Statements in the press release 908 Devices issued today.

For a more complete listing description, please see the Risk Factors section of the company's annual report on Form 10-K for the year ended December 31, 2022, and in its other filings with the Securities and Exchange Commission. Except as required by law, 908 Devices disclaims any intention or obligation to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise. This conference call contains time-sensitive information and is accurate only as of the live broadcast, August 8, 2023.

With that, I would like to turn the call over to Kevin.

Kevin Knopp

Thanks, Kelly. Good morning, and thank you for joining our second quarter 2023 earnings call. I'd like to start off by thanking our team for their continued dedication and commitment to serving our customers and for bringing our second quarter to a successful close. At 908, we have a broad technology platform with applications across diverse end markets.

Our handheld devices are serving critical forensics market applications, including the devastating rise of counterfeit pharmaceuticals, and our growing portfolio of desktop products is serving life science and biopharma applications, including the emergence of multi omics research and the ascent of Bioprocess 4.0. We view our end market diversity as a key advantage, particularly in the current macro environment, and this was reflected in our financial results.